Trexo Theo
FDA-cleared prescription powered lower-limb exoskeleton for ambulatory function in people aged 12 and older with cerebral palsy.
Product Overview
Trexo Theo is a prescription powered exoskeleton cleared by the FDA for ambulatory functions in people aged 12 and older with cerebral palsy. It is intended for supervised community or clinical use; US deliveries are planned for 2027 following assessment, prescription and training.
Positioning & Buyer Fit
Prescription-powered ambulatory support for pediatric cerebral palsy.
Families and clinical teams evaluating a prescription device for supervised ambulatory function.
Use Case & Product Classification
Powered Lower Limb Exoskeleton
Product Highlights & Manufacturer Claims
- FDA 510(k) cleared K254198
- Ages 12+ with cerebral palsy
- Supervised use
- US deliveries planned for 2027
Verified against current official manufacturer source on 2026-09-12.
Pricing & Commercial Access
Ships from US deliveries begin in 2027
Price checked 12/09/2026Current public commercial routes tracked by Exoskeleton Index.
- Ships from US deliveries begin in 2027
Tell us about your task, users, industry and region. We can help identify relevant products, suppliers and practical next steps.